HCA Healthcare报告2023年第四季度业绩并提供2024年指导-动脉网

HCA Healthcare Reports Fourth Quarter 2023 Results and Provides 2024 Guidance

businesswire 等信源发布 2024-01-30 19:30



可切换为仅中文







NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the fourth quarter ended December 31, 2023.

田纳西州纳什维尔（商业新闻短讯）--HCA Healthcare，Inc.（纽约证券交易所代码：HCA）今天宣布了截至2023年12月31日的第四季度的财务和经营业绩。

Key fourth quarter metrics (all percentage changes compare 4Q 2023 to 4Q 2022 unless otherwise noted):

关键的第四季度指标（除非另有说明，所有百分比变化均将2023年第四季度与2022年第四季度进行比较）：

Revenues totaled $17.303 billion

收入总计173.03亿美元

Net income attributable to HCA Healthcare, Inc. totaled $1.607 billion, or $5.93 per diluted share

归属于HCA Healthcare，Inc.的净收入总计16.07亿美元，或稀释后每股5.93美元

Adjusted EBITDA totaled $3.618 billion

调整后的息税折旧摊销前利润总计36.18亿美元

Cash flows from operating activities totaled $2.674 billion

经营活动产生的现金流总计26.74亿美元

Same facility admissions increased 3.1 percent while same facility equivalent admissions increased 3.9 percent

同一设施的入学人数增加了3.1%，而同等设施的入学人数增加了3.9%

“In the quarter, we experienced strong demand for services across our diversified portfolio of markets, facilities, and service lines. This growth coupled with improved cost trends drove solid financial performance in the fourth quarter. Once again, our people have delivered positive outcomes for our patients, the communities we serve, and our other stakeholders.

“在本季度，我们在市场、设施和服务线的多元化组合中经历了强烈的服务需求。这种增长加上成本趋势的改善，推动了第四季度稳健的财务表现。我们的员工再次为患者、我们服务的社区和其他利益相关者带来了积极的成果。

I want to thank them for their hard work and everything they do for our company,” said Sam Hazen, Chief Executive Officer of HCA Healthcare..

我要感谢他们的辛勤工作和为我们公司所做的一切，”HCA Healthcare首席执行官萨姆·哈森（SamHazen）表示。。

Revenues in the fourth quarter of 2023 totaled $17.303 billion, compared to $15.497 billion in the fourth quarter of 2022. Net income attributable to HCA Healthcare, Inc. totaled $1.607 billion, or $5.93 per diluted share, compared to $2.081 billion, or $7.28 per diluted share, in the fourth quarter of 2022.

2023年第四季度的总收入为173.03亿美元，而2022年第四季度为154.97亿美元。归属于HCA Healthcare，Inc.的净收入总计16.07亿美元，或摊薄后每股5.93美元，而2022年第四季度为20.81亿美元，或摊薄后每股7.28美元。

Results for the fourth quarter of 2023 include gains on sales of facilities of $7 million, or $0.03 per diluted share. Results for the fourth quarter of 2022 include gains on sales of facilities of $1.326 billion, or $2.64 per diluted share, related to sales of our controlling interests in certain healthcare entities..

2023年第四季度的业绩包括700万美元的设施销售收益，即稀释后每股0.03美元。2022年第四季度的业绩包括设施销售收益13.26亿美元，或摊薄后每股2.64美元，与我们在某些医疗保健实体的控股权益的销售有关。。

For the fourth quarter of 2023, Adjusted EBITDA totaled $3.618 billion, compared to $3.179 billion in the fourth quarter of 2022. Adjusted EBITDA is a non-GAAP financial measure. A table providing supplemental information on Adjusted EBITDA and reconciling net income attributable to HCA Healthcare, Inc.

2023年第四季度，调整后的息税折旧摊销前利润总计36.18亿美元，而2022年第四季度为31.79亿美元。调整后的息税折旧摊销前利润是一项非公认会计准则财务指标。该表提供了调整后息税折旧摊销前利润的补充信息，并调整了归属于HCA Healthcare，Inc.的净收入。

to Adjusted EBITDA is included in this release. Same facility admissions increased 3.1 percent while same facility equivalent admissions increased 3.9 percent in the fourth quarter of 2023, compared to the prior year period. Same facility emergency room visits increased 2.1 percent in the fourth quarter of 2023, compared to the prior year period.

调整后的息税折旧摊销前利润包含在本版本中。2023年第四季度，与上年同期相比，同一设施的入学人数增加了3.1%，而同等设施的入学人数增加了3.9%。与上年同期相比，2023年第四季度，同一设施的急诊室就诊人数增加了2.1%。

Same facility inpatient surgeries increased 1.0 percent, and same facility outpatient surgeries increased 0.7 percent in the fourth quarter of 2023, compared to the same period of 2022. Same facility revenue per equivalent admission increased 6.9 percent in the fourth quarter of 2023, compared to the fourth quarter of 2022..

与2022年同期相比，2023年第四季度，同一设施的住院手术增加了1.0%，同一设施的门诊手术增加了0.7%。与2022年第四季度相比，2023年第四季度，每套同等门票的同一设施收入增长了6.9%。。

Year Ended December 31, 2023

截至2023年12月31日止年度

Revenues for the year ended December 31, 2023 totaled $64.968 billion, compared to $60.233 billion for the year ended December 31, 2022. Net income attributable to HCA Healthcare, Inc. was $5.242 billion, or $18.97 per diluted share, for the year ended December 31, 2023 compared to $5.643 billion, or $19.15 per diluted share, for the year ended December 31, 2022.

截至2023年12月31日的财年收入总计649.68亿美元，而截至2022年12月31日的财年收入为602.33亿美元。截至2023年12月31日，归属于HCA Healthcare，Inc.的净收入为52.42亿美元，即每股摊薄后的18.97美元，而截至2022年12月31日，归属于HCA Healthcare，Inc.的净收入为56.43亿美元，即每股摊薄后的19.15美元。

Results for the year ended December 31, 2023 include losses on sales of facilities of $5 million, or $0.04 per diluted share. Results for the year ended December 31, 2022 include gains on sales of facilities of $1.301 billion, or $2.46 per diluted share, and losses on retirement of debt of $78 million, or $0.20 per diluted share..

截至2023年12月31日止之财年的业绩包括500万美元的设施销售损失，即稀释后每股0.04美元。截至2022年12月31日止之财年的业绩包括13.01亿美元（稀释后每股2.46美元）的贷款销售收益和7800万美元（稀释后每股0.20美元）的债务偿还损失。。

For 2023, Adjusted EBITDA totaled $12.726 billion, compared to $12.067 billion in 2022. Adjusted EBITDA is a non-GAAP financial measure. A table providing supplemental information on Adjusted EBITDA and reconciling net income attributable to HCA Healthcare, Inc. to Adjusted EBITDA is included in this release..

2023年，调整后的息税折旧摊销前利润总额为127.26亿美元，而2022年为120.67亿美元。调整后的息税折旧摊销前利润是一项非公认会计准则财务指标。本版本中包含一个表格，该表格提供了调整后息税折旧摊销前利润的补充信息，并将归属于HCA Healthcare，Inc.的净收入与调整后息税折旧摊销前利润进行了对账。。

Balance Sheet and Cash Flows from Operations

资产负债表和经营活动产生的现金流量

As of December 31, 2023, HCA Healthcare, Inc.’s balance sheet reflected cash and cash equivalents of $935 million, total debt of $39.593 billion, and total assets of $56.211 billion. During the fourth quarter of 2023, capital expenditures totaled $1.159 billion, excluding acquisitions. Cash flows provided by operating activities in the fourth quarter of 2023 totaled $2.674 billion, compared to $2.527 billion in the fourth quarter of 2022..

截至2023年12月31日，HCA Healthcare，Inc.的资产负债表显示现金和现金等价物为9.35亿美元，总债务为395.93亿美元，总资产为562.11亿美元。2023年第四季度，不包括收购，资本支出总计11.59亿美元。2023年第四季度，经营活动产生的现金流总计为26.74亿美元，而2022年第四季度为25.27亿美元。。

During the fourth quarter of 2023, the Company repurchased 3.647 million shares of its common stock at a cost of $910 million. The Company had $775 million remaining under its repurchase authorization as of December 31, 2023. As of December 31, 2023, the Company had $6.107 billion of availability under its credit facilities..

2023年第四季度，该公司以9.1亿美元的价格回购了364.7万股普通股。截至2023年12月31日，该公司在回购授权下剩余7.75亿美元。截至2023年12月31日，该公司拥有61.07亿美元的信贷额度。。

Share Repurchase Program

股份回购计划

The HCA Healthcare, Inc. Board of Directors has authorized an additional share repurchase program for up to $6 billion of the Company’s outstanding common stock. Repurchases will be made in accordance with applicable securities laws and may be made at management’s discretion from time to time in the open market, through privately negotiated transactions, or otherwise.

HCA Healthcare，Inc.董事会批准了一项额外的股份回购计划，以回购公司高达60亿美元的已发行普通股。回购将根据适用的证券法进行，并可由管理层不时在公开市场上通过私下协商交易或其他方式自行决定。

The repurchase program has no time limit and may be suspended for periods or discontinued at any time..

回购计划没有时间限制，可能会暂停一段时间或随时停止。。

Dividend

股息

HCA today announced that its Board of Directors declared a quarterly cash dividend of $0.66 per share on the Company’s common stock. The dividend will be paid on March 29, 2024 to stockholders of record at the close of business on March 15, 2024.

HCA今天宣布，其董事会宣布该公司普通股的季度现金股息为每股0.66美元。股息将于2024年3月29日支付给2024年3月15日营业结束时登记在册的股东。

The declaration and payment of any future dividend will be subject to the discretion of the Board of Directors and will depend on a variety of factors, including the Company’s financial condition, results of operations, and contractual restrictions. Future dividends are expected to be funded by cash balances and future cash flows from operations..

任何未来股息的宣布和支付将由董事会自行决定，并取决于多种因素，包括公司的财务状况、经营成果和合同限制。未来股息预计将由现金余额和未来经营现金流提供资金。。

2024 Guidance

2024年指南

Today, the Company issued the following estimated guidance for 2024:

今天，该公司发布了以下2024年的预计指南：

2024 Guidance Range

2024制导范围

Revenues

收入

$67.75 to $70.25 billion

677.5亿美元至702.5亿美元

Net Income Attributable to HCA Healthcare, Inc.

归属于HCA Healthcare，Inc.的净收入。

$5.20 to $5.60 billion

52亿至56亿美元

Adjusted EBITDA

调整后息税折旧摊销前利润

$12.85 to $13.55 billion

128.5亿至135.5亿美元

EPS (diluted)

每股收益（稀释）

$19.70 to $21.20 per diluted share

稀释后每股19.70美元至21.20美元

Capital expenditures for 2024, excluding acquisitions, are estimated to be in the range of $5.1 to $5.3 billion.

2024年的资本支出（不包括收购）估计在51亿至53亿美元之间。

The Company’s 2024 guidance contains a number of assumptions, including, among others, the Company’s current expectations regarding patient volumes and payor mix as well as general economic conditions, including inflation, and excludes the impact of items such as, but not limited to, gains or losses on sales of facilities, losses on retirement of debt, legal claims costs and impairment of long-lived assets..

公司2024年指南包含许多假设，其中包括公司目前对患者数量和付款人组合的预期以及包括通货膨胀在内的一般经济状况，不包括但不限于设施销售损益、债务偿还损失等项目的影响，长期资产的法律索赔成本和减值。。

Adjusted EBITDA is a non-GAAP financial measure. A table reconciling forecasted net income attributable to HCA Healthcare, Inc. to forecasted Adjusted EBITDA is included in this release.

调整后的息税折旧摊销前利润是一项非公认会计准则财务指标。本版本中包含了一个将归属于HCA Healthcare，Inc.的预测净收入与预测调整后息税折旧摊销前利润进行对账的表格。

The Company’s guidance is based on current plans and expectations and is subject to a number of known and unknown uncertainties and risks, including those set forth below in the Company’s “Forward-Looking Statements.”

本公司的指导方针基于当前的计划和预期，并受到许多已知和未知的不确定性和风险的影响，包括本公司“前瞻性声明”中所述的不确定性和风险

CFO Announcement

首席财务官公告

HCA Healthcare is also announcing today that Bill Rutherford has decided to retire as Executive Vice President and Chief Financial Officer (“CFO”) after a 34-year career with the company. Mike Marks, HCA Healthcare’s current Senior Vice President, Finance, will succeed Mr. Rutherford as Executive Vice President and CFO, effective May 1, 2024..

HCA Healthcare今天还宣布，比尔·卢瑟福（BillRutherford）在该公司任职34年后，决定辞去执行副总裁兼首席财务官（CFO）的职务。HCA Healthcare现任财务高级副总裁迈克·马克斯（MikeMarks）将接替卢瑟福（Rutherford）担任执行副总裁兼首席财务官，自2024年5月1日起生效。。

“Bill has announced his plan to retire from HCA after 34 years with the company,” said Sam Hazen, Chief Executive Officer of HCA Healthcare. “Bill has had a tremendous impact during his ten years as CFO. The impressive operating results and shareholder returns achieved throughout his tenure are a testament to his leadership and disciplined approach to driving profitable growth.

HCA Healthcare首席执行官萨姆·哈森（SamHazen）表示：“比尔（Bill）宣布了他在HCA工作34年后退休的计划。”。“比尔在担任首席财务官的十年中产生了巨大的影响。在他任职期间取得的令人印象深刻的经营成果和股东回报证明了他在推动利润增长方面的领导才能和纪律性。

Without question, Bill’s legacy will endure.”.

毫无疑问，比尔的遗产将永存。”。

“Bill has also developed an incredibly high-performing finance team, including Mike, who is an accomplished finance professional and respected leader. I am thrilled for Mike to take on the CFO role and couldn’t be more confident in his ability to continue to advance our company’s success,” said Hazen.

哈森说：“比尔还培养了一支表现异常出色的财务团队，其中包括迈克，他是一位才华横溢的财务专业人士，也是一位受人尊敬的领导者。我很高兴迈克能担任首席财务官的角色，对他继续推动公司取得成功的能力充满信心。”。

“I want to thank Bill for his many contributions to HCA and congratulate him on his upcoming retirement. I also want to welcome Mike as the new CFO,” said Hazen. “Mike has worked closely with Bill, the senior team, and myself. He will be an exceptional CFO as we continue to deliver on our commitment to the care and improvement of human life while keeping our financial foundation strong.”.

哈森说：“我要感谢比尔为HCA做出的诸多贡献，并祝贺他即将退休。我还想欢迎迈克出任新首席财务官。”。“迈克（Mike）与比尔（Bill）、高级团队和我本人都有着密切的合作。他将是一位出色的首席财务官，因为我们将继续履行我们对关爱和改善人类生活的承诺，同时保持我们强大的财务基础。”。

Mr. Marks joined HCA Healthcare in 1996 and has held a number of positions in accounting and finance, including Senior Vice President — Finance, Vice President — Financial Operations Support, CFO of the National Group and CFO of the West Florida Division.

Marks先生于1996年加入HCA Healthcare，曾在会计和财务领域担任多个职位，包括财务高级副总裁、财务运营支持副总裁、National Group首席财务官和西佛罗里达分部首席财务官。

Annual Stockholders’ Meeting

年度股东大会

The Company’s 2024 annual stockholders’ meeting will be held virtually on April 25, 2024 at 2:00 p.m. Central Time for stockholders of record as of February 26, 2024.

截至2024年2月26日，公司2024年年度股东大会将于2024年4月25日中部时间下午2:00举行。

Earnings Conference Call

收益电话会议

HCA Healthcare will host a conference call for investors at 9:00 a.m. Central Time today. All interested investors are invited to access a live audio broadcast of the call via webcast. The broadcast also will be available on a replay basis beginning this afternoon. The webcast can be accessed through the Company’s Investor Relations web page at https://investor.hcahealthcare.com/events-and-presentations/default.aspx..

HCA Healthcare将于今天中部时间上午9:00为投资者召开电话会议。所有感兴趣的投资者都被邀请通过网络广播进行电话直播。从今天下午开始，广播也将以重播方式播放。该网络广播可通过公司的投资者关系网页访问，网址为https://investor.hcahealthcare.com/events-and-presentations/default.aspx..

About the Company

关于公司

As of December 31, 2023, HCA operated 186 hospitals and approximately 2,400 ambulatory sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics, in 20 states and the United Kingdom.

截至2023年12月31日，HCA在20个州和英国运营了186家医院和大约2400个门诊护理点，包括手术中心、独立急诊室、紧急护理中心和医生诊所。

Forward-Looking Statements

前瞻性声明

This press release contains forward-looking statements within the meaning of the federal securities laws, which involve risks and uncertainties. Forward-looking statements include the Company’s financial guidance for the year ending December 31, 2024, as well as other statements that do not relate solely to historical or current facts.

本新闻稿包含联邦证券法所指的前瞻性声明，涉及风险和不确定性。前瞻性报表包括公司截至2024年12月31日止年度的财务指导，以及其他不完全与历史或当前事实相关的报表。

Forward-looking statements can be identified by the use of words like “may,” “believe,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “initiative” or “continue.” These forward-looking statements are based on our current plans and expectations and are subject to a number of known and unknown uncertainties and risks, many of which are beyond our control, which could significantly affect current plans and expectations and our future financial position and results of operations.

前瞻性陈述可以通过使用“可能”、“相信”、“将会”、“期望”、“项目”、“估计”、“预期”、“计划”、“倡议”或“继续”等词来识别。这些前瞻性陈述基于我们目前的计划和期望，并受到许多已知和未知的不确定性和风险的影响，其中许多超出了我们的控制范围，这可能会严重影响当前的计划和预期以及我们未来的财务状况和经营成果。

These factors include, but are not limited to, (1) changes in or related to general economic conditions nationally and regionally in our markets, including inflation and economic and business conditions (and the impact thereof on the economy, financial markets and banking industry); changes in revenues due to declining patient volumes; changes in payer mix (including increases in uninsured and underinsured patients); potential increased expenses related to labor, supply chain or other expenditures; workforce disruptions; supply shortages and disruptions (including as a result of geopolitical disruptions); and the impact of potential federal government shutdowns, (2) the impact of our significant indebtedness and the ability to refinance such indebtedness on acceptable terms, (3) the impact of current and future federal and state health reform initiatives and possible changes to other federal, state or local laws and regulations affecting the health ca.

这些因素包括但不限于：（1）国内和地区市场总体经济状况的变化或与之相关的变化，包括通货膨胀、经济和商业状况（及其对经济、金融市场和银行业的影响）；患者数量下降导致收入变化；付款人组合的变化（包括未投保和未投保患者的增加）；与劳动力、供应链或其他支出相关的潜在增加费用；劳动力中断；供应短缺和中断（包括地缘政治中断）；以及潜在的联邦政府关门的影响，（2）我们的重大债务的影响以及以可接受的条款对此类债务进行再融资的能力，（3）当前和未来的联邦和州卫生改革举措的影响以及影响卫生ca的其他联邦，州或地方法律法规的可能变化。

HCA Healthcare, Inc.

HCA医疗保健股份有限公司。

Condensed Consolidated Comprehensive Income Statements

简明综合损益表

Fourth Quarter

第四季度

Unaudited

未经审计

(Dollars in millions, except per share amounts)

（百万美元，每股金额除外）

2023

2022

Amount

金额

Ratio

比率

Amount

金额

Ratio

比率

Revenues

收入

$17,303

100.0

$15,497

100.0

Salaries and benefits

薪资与福利

7,570

43.7

7,055

45.5

Supplies

供应品

2,584

14.9

2,429

15.7

Other operating expenses

其他营业费用

3,559

20.7

2,850

18.4

Equity in earnings of affiliates

附属公司收益中的权益

(28

)

(0.2

)

(16

)

(0.1

)

Depreciation and amortization

折旧和摊销

789

4.5

750

4.9

Interest expense

利息支出

491

2.8

453

2.9

Gains on sales of facilities

设施销售收益

)

(1,326

)

(8.6

)

14,958

86.4

12,195

78.7

Income before income taxes

所得税前收入

2,345

13.6

3,302

21.3

Provision for income taxes

所得税准备金

484

2.8

656

4.2

Net income

净收入

1,861

10.8

2,646

17.1

Net income attributable to noncontrolling interests

归属于非控股权益的净收入

254

1.5

565

3.7

Net income attributable to HCA Healthcare, Inc.

归属于HCA Healthcare，Inc.的净收入。

$1,607

9.3

$2,081

13.4

Diluted earnings per share

稀释每股收益

$5.93

$7.28

Shares used in computing diluted earnings per share (millions)

用于计算稀释每股收益的股份（百万）

271.186

285.663

Comprehensive income attributable to HCA Healthcare, Inc.

归属于HCA Healthcare，Inc.的综合收入。

$1,673

$2,183

HCA Healthcare, Inc.

HCA医疗保健股份有限公司。

Condensed Consolidated Comprehensive Income Statements

简明综合损益表

For the Years Ended December 31, 2023 and 2022

截至2023年和2022年12月31日的年度

Unaudited

未经审计

(Dollars in millions, except per share amounts)

（百万美元，每股金额除外）

2023

2022

Amount

金额

Ratio

比率

Amount

金额

Ratio

比率

Revenues

收入

$64,968

100.0

$60,233

100.0

Salaries and benefits

薪资与福利

29,487

45.4

27,685

46.0

Supplies

9,902

15.2

9,371

15.6

Other operating expenses

其他营业费用

12,875

19.8

11,155

18.5

Equity in earnings of affiliates

附属公司收益中的权益

(22

)

-（笑声）

(45

)

(0.1

)

Depreciation and amortization

折旧和摊销

3,077

4.7

2,969

5.0

Interest expense

利息支出

1,938

3.0

1,741

2.9

Losses (gains) on sales of facilities

设施销售损失（收益）

-（笑声）

(1,301

)

(2.2

)

Losses on retirement of debt

债务偿还损失

-（笑声）

0.1

57,262

88.1

51,653

85.8

Income before income taxes

所得税前收入

7,706

11.9

8,580

14.2

Provision for income taxes

所得税准备金

1,615

2.5

1,746

2.9

Net income

净收入

6,091

9.4

6,834

11.3

Net income attributable to noncontrolling interests

归属于非控股权益的净收入

849

1.3

1,191

1.9

Net income attributable to HCA Healthcare, Inc.

归属于HCA Healthcare，Inc.的净收入。

$5,242

8.1

$5,643

9.4

Diluted earnings per share

稀释每股收益

$18.97

$19.15

Shares used in computing diluted earnings per share (millions)

用于计算稀释每股收益的股份（百万）

276.412

294.666

Comprehensive income attributable to HCA Healthcare, Inc.

归属于HCA Healthcare，Inc.的综合收入。

$5,307

$5,557

HCA Healthcare, Inc.

HCA医疗保健股份有限公司。

Condensed Consolidated Balance Sheets

简明合并资产负债表

Unaudited

未经审计

(Dollars in millions)

（百万美元）

December 31,

12月31日，

September 30,

9月30日，

December 31,

12月31日，

2023

2022

ASSETS

资产

Current assets:

流动资产：

Cash and cash equivalents

现金及现金等价物

$935

$891

$908

Accounts receivable

应收账款

9,958

9,182

8,891

Inventories

存货

2,021

2,030

2,068

Other

其他

2,013

2,191

1,776

14,927

14,294

13,643

Property and equipment, at cost

58,548

57,772

54,757

Accumulated depreciation

累计折旧

(30,833

)

(30,655

)

(29,182

)

27,715

27,117

25,575

Investments of insurance subsidiaries

保险子公司投资

477

382

381

Investments in and advances to affiliates

对附属公司的投资和预付款

756

739

823

Goodwill and other intangible assets

商誉和其他无形资产

9,945

9,778

9,653

Right-of-use operating lease assets

经营租赁资产使用权

2,207

2,079

2,065

Other

其他

184

200

298

$56,211

$54,589

$52,438

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

Current liabilities:

流动负债：

Accounts payable

应付账款

$4,233

$4,139

$4,239

Accrued salaries

应计工资

2,127

1,912

1,712

Other accrued expenses

其他应计费用

3,871

3,803

3,581

Long-term debt due within one year

一年内到期的长期债务

2,424

2,553

370

12,655

12,407

9,902

Long-term debt, less debt issuance costs and discounts of $333, $341 and $301

长期债务，减去债务发行成本和333美元、341美元和301美元的折扣

37,169

36,793

37,714

Professional liability risks

职业责任风险

1,557

1,590

1,528

Right-of-use operating lease obligations

使用权经营租赁义务

1,903

1,776

1,752

Income taxes and other liabilities

所得税和其他负债

1,867

1,666

1,615

Stockholders' equity (deficit):

股东权益（赤字）：

Stockholders' deficit attributable to HCA Healthcare, Inc.

归属于HCA Healthcare，Inc.的股东赤字。

(1,774

)

(2,477

)

(2,767

)

Noncontrolling interests

非控股权益

2,834

2,694

1,060

357

(73

)

$56,211

$54,589

$52,438

HCA Healthcare, Inc.

HCA医疗保健股份有限公司。

Condensed Consolidated Statements of Cash Flows

简明合并现金流量表

For the Years Ended December 31, 2023 and 2022

截至2023年和2022年12月31日的年度

Unaudited

未经审计

(Dollars in millions)

（百万美元）

2023

2022

Cash flows from operating activities:

经营活动产生的现金流量：

Net income

净收入

$6,091

$6,834

Adjustments to reconcile net income to net cash provided by operating activities:

将净收入调整为经营活动产生的净现金：

Increase (decrease) in cash from operating assets and liabilities:

经营资产和负债产生的现金增加（减少）：

Accounts receivable

应收账款

(935

)

(797

)

Inventories and other assets

存货和其他资产

(126

)

(59

)

Accounts payable and accrued expenses

应付账款和应计费用

604

(296

)

Depreciation and amortization

折旧和摊销

3,077

2,969

Income taxes

所得税

229

571

Losses (gains) on sales of facilities

设施销售损失（收益）

(1,301

)

Losses on retirement of debt

债务偿还损失

Amortization of debt issuance costs and discounts

债务发行成本和折扣的摊销

Share-based compensation

股份制薪酬

262

341

Other

其他

189

153

Net cash provided by operating activities

经营活动产生的现金净额

9,431

8,522

Cash flows from investing activities:

投资活动产生的现金流量：

Purchase of property and equipment

购买物业和设备

(4,744

)

(4,395

)

Acquisition of hospitals and health care entities

收购医院和医疗保健实体

(635

)

(224

)

Sales of hospitals and health care entities

医院和医疗保健实体的销售

193

1,237

Change in investments

投资变动

(112

)

Other

其他

(19

)

(21

)

Net cash used in investing activities

用于投资活动的现金净额

(5,317

)

(3,389

)

Cash flows from financing activities:

融资活动产生的现金流：

Issuances of long-term debt

发行长期债务

3,224

5,997

Net change in revolving credit facilities

循环贷款净变动

(1,020

)

120

Repayment of long-term debt

偿还长期债务

(909

)

(2,830

)

Distributions to noncontrolling interests

非控股权益分配

(640

)

(1,025

)

Payment of debt issuance costs

支付债务发行成本

(31

)

(53

)

Payment of dividends

股息的支付

(661

)

(653

)

Repurchase of common stock

回购普通股

(3,811

)

(7,000

)

Other

其他

(246

)

(212

)

Net cash used in financing activities

用于融资活动的现金净额

(4,094

)

(5,656

)

Effect of exchange rate changes on cash and cash equivalents

汇率变动对现金及现金等价物的影响

(20

)

Change in cash and cash equivalents

现金及现金等价物变动

(543

)

Cash and cash equivalents at beginning of period

期初现金及现金等价物

908

1,451

Cash and cash equivalents at end of period

期末现金及现金等价物

$935

$908

Interest payments

利息支付

$1,892

$1,662

Income tax payments, net

所得税支付净额

$1,386

$1,175

HCA Healthcare, Inc.

HCA医疗保健股份有限公司。

Operating Statistics

运营统计

For the Years

多年来

Fourth Quarter

第四季度

Ended December 31,

截至12月31日，

2023

2022

2023

2022

Operations:

操作：

Number of Hospitals

医院数量

186

182

186

182

Number of Freestanding Outpatient Surgery Centers*

独立门诊手术中心数量*

124

126

124

126

Licensed Beds at End of Period

期末持牌床位

49,588

49,281

49,588

49,281

Weighted Average Beds in Service

使用中的加权平均床位

42,072

42,119

41,873

41,982

Reported:

已报告：

Admissions

招生

544,554

530,298

2,130,728

2,075,459

% Change

%更改

2.7

Equivalent Admissions

同等入学人数

974,561

931,990

3,788,434

3,611,299

% Change

%更改

4.6

4.9

Revenue per Equivalent Admission

每次同等门票收入

17,755

16,628

17,149

16,679

% Change

%更改

6.8

2.8

Inpatient Revenue per Admission

每次入院的住院收入

18,992

17,634

18,201

17,361

% Change

%更改

7.7

4.8

Patient Days

患者天数

2,674,331

2,648,683

10,483,236

10,504,145

% Change

%更改

1.0

-0.2

Equivalent Patient Days

等效患者天数

4,786,197

4,655,841

18,639,194

18,277,212

% Change

%更改

2.8

2.0

Inpatient Surgery Cases

住院手术病例

132,417

131,840

528,845

522,151

% Change

%更改

0.4

1.3

Outpatient Surgery Cases

门诊手术病例

270,286

265,610

1,044,415

1,023,239

% Change

%更改

1.8

2.1

Emergency Room Visits

急诊室就诊

2,452,395

2,412,781

9,342,783

8,971,951

% Change

%更改

1.6

4.1

Outpatient Revenues as a

门诊收入作为

Percentage of Patient Revenues

患者收入百分比

38.4

37.5

38.3

37.6

Average Length of Stay (days)

平均住院时间（天）

4.911

4.995

4.920

5.061

Occupancy**

占用率**

72.5

72.0

72.3

72.1

Same Facility:

同一设施：

Admissions

招生

542,628

526,259

2,127,112

2,059,561

% Change

%更改

3.1

3.3

Equivalent Admissions

同等入学人数

959,366

923,585

3,750,098

3,577,457

% Change

%更改

3.9

4.8

Revenue per Equivalent Admission

每次同等门票收入

17,672

16,533

17,080

16,637

% Change

%更改

6.9

2.7

Inpatient Revenue per Admission

每次入院的住院收入

19,025

17,530

18,210

17,313

% Change

%更改

8.5

5.2

Inpatient Surgery Cases

住院手术病例

132,056

130,804

528,085

517,898

% Change

%更改

1.0

2.0

Outpatient Surgery Cases

门诊手术病例

263,398

261,685

1,026,639

1,002,076

% Change

%更改

0.7

2.5

Emergency Room Visits

急诊室就诊

2,445,405

2,395,650

9,328,741

8,907,055

% Change

%更改

2.1

4.7

* Excludes freestanding endoscopy centers (24 centers at December 31, 2023 and 21 centers at December 31, 2022).

*不包括独立的内窥镜检查中心（2023年12月31日为24个中心，2022年12月31日为21个中心）。

** Reflects the rate of occupancy (patient days and observations) based on weighted average beds in service.

**反映基于加权平均服务床位的入住率（患者天数和观察值）。

HCA Healthcare, Inc.

HCA医疗保健股份有限公司。

Supplemental Non-GAAP Disclosures

补充非GAAP披露

Operating Results Summary

经营成果汇总

(Dollars in millions, except per share amounts)

（百万美元，每股金额除外）

For the Years

多年来

Fourth Quarter

第四季度

Ended December 31,

截至12月31日，

2023

2022

2023

2022

Revenues

收入

$17,303

$15,497

$64,968

$60,233

Net income attributable to HCA Healthcare, Inc.

归属于HCA Healthcare，Inc.的净收入。

$1,607

$2,081

$5,242

$5,643

Losses (gains) on sales of facilities (net of tax)

设施销售损失（收益）（税后）

)

(755

)

(727

)

Losses on retirement of debt (net of tax)

债务偿还损失（税后）

-（笑声）

Net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of facilities and losses on retirement of debt (a)

归属于HCA Healthcare，Inc.的净收入，不包括设施销售损失（收益）和债务偿还损失（a）

1,598

1,326

5,254

4,976

Depreciation and amortization

折旧和摊销

789

750

3,077

2,969

Interest expense

利息支出

491

453

1,938

1,741

Provision for income taxes

所得税准备金

486

422

1,608

1,527

Net income attributable to noncontrolling interests (b)

归属于非控股权益的净收入（b）

254

228

849

854

Adjusted EBITDA (a)

调整后息税折旧摊销前利润（a）

$3,618

$3,179

$12,726

$12,067

Adjusted EBITDA margin (a)

调整后息税折旧摊销前利润率（a）

20.9

20.5

19.6

20.0

Diluted earnings per share:

稀释每股收益：

Net income attributable to HCA Healthcare, Inc.

归属于HCA Healthcare，Inc.的净收入。

$5.93

$7.28

$18.97

$19.15

Losses (gains) on sales of facilities

设施销售损失（收益）

(0.03

)

(2.64

)

0.04

(2.46

)

Losses on retirement of debt

债务偿还损失

-（笑声）

0.20

Net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of facilities and losses on retirement of debt (a)

归属于HCA Healthcare，Inc.的净收入，不包括设施销售损失（收益）和债务偿还损失（a）

$5.90

$4.64

$19.01

$16.89

Shares used in computing diluted earnings per share (millions)

用于计算稀释每股收益的股份（百万）

271.186

285.663

276.412

294.666

________________________________________________________

(a)

（一）

Net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of facilities and losses on retirement of debt, and Adjusted EBITDA should not be considered as measures of financial performance under generally accepted accounting principles ('GAAP'). We believe net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of facilities and losses on retirement of debt, and Adjusted EBITDA are important measures that supplement discussions and analysis of our results of operations.

归属于HCA Healthcare，Inc.的净收入，不包括设施销售损失（收益）和债务偿还损失，以及调整后的息税折旧摊销前利润，不应视为公认会计原则（“GAAP”）下的财务业绩衡量指标。我们认为，归属于HCA Healthcare，Inc.的净收入（不包括设施销售损失（收益）、债务偿还损失以及调整后的息税折旧摊销前利润）是补充我们经营成果讨论和分析的重要指标。

We believe it is useful to investors to provide disclosures of our results of operations on the same basis used by management. Management relies upon net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of facilities and losses on retirement of debt, and Adjusted EBITDA as the primary measures to review and assess operating performance of its health care facilities and their management teams..

我们认为，在管理层使用的相同基础上披露我们的经营成果对投资者很有用。管理层依赖于归属于HCA Healthcare，Inc.的净收入，不包括设施销售损失（收益）和债务偿还损失，以及调整后的息税折旧摊销前利润，作为审查和评估其医疗保健设施及其管理团队经营业绩的主要措施。。

Management and investors review both the overall performance (including net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of facilities and losses on retirement of debt, and GAAP net income attributable to HCA Healthcare, Inc.) and operating performance (Adjusted EBITDA) of our health care facilities.

管理层和投资者审查我们医疗保健设施的整体业绩（包括归属于HCA Healthcare，Inc.的净收入，不包括设施销售损失（收益）和债务偿还损失，以及归属于HCA Healthcare，Inc.的GAAP净收入）和经营业绩（调整后的息税折旧摊销前利润）。

Adjusted EBITDA and the Adjusted EBITDA margin (Adjusted EBITDA divided by revenues) are utilized by management and investors to compare our current operating results with the corresponding periods during the previous year and to compare our operating results with other companies in the health care industry.

管理层和投资者利用调整后的息税折旧摊销前利润和调整后的息税折旧摊销前利润（调整后的息税折旧摊销前利润除以收入），将我们目前的经营业绩与上年同期进行比较，并将我们的经营业绩与医疗保健行业的其他公司进行比较。

It is reasonable to expect that losses (gains) on sales of facilities and losses on retirement of debt will occur in future periods, but the amounts recognized can vary significantly from period to period, do not directly relate to the ongoing operations of our health care facilities and complicate period comparisons of our results of operations and operations comparisons with other health care companies..

可以合理预期，设施销售的损失（收益）和债务偿还的损失将在未来期间发生，但确认的金额可能因时期而异，不要直接与我们医疗保健设施的持续运营相关，也不要将我们的运营结果与其他医疗保健公司的运营结果进行复杂的时期比较。。

Net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of facilities and losses on retirement of debt, and Adjusted EBITDA are not measures of financial performance under GAAP, and should not be considered as alternatives to net income attributable to HCA Healthcare, Inc.

归属于HCA Healthcare，Inc.的净收入，不包括设施销售损失（收益）和债务偿还损失，以及调整后的息税折旧摊销前利润，不是GAAP下的财务业绩指标，不应被视为归属于HCA Healthcare，Inc.的净收入的替代品。

as a measure of operating performance or cash flows from operating, investing and financing activities as a measure of liquidity. Because net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of facilities and losses on retirement of debt, and Adjusted EBITDA are not measurements determined in accordance with GAAP and are susceptible to varying calculations, net income attributable to HCA Healthcare, Inc., excluding losses (gains) on sales of facilities and losses on retirement of debt, and Adjusted EBITDA, as presented, may not be comparable to other similarly titled measures presented by other companies..

衡量经营业绩或经营、投资和融资活动产生的现金流，作为衡量流动性的指标。由于归属于HCA Healthcare，Inc.的净收入（不包括设施销售损失（收益）和债务偿还损失）以及调整后的息税折旧摊销前利润（EBITDA）不是根据公认会计准则确定的衡量标准，并且易于进行不同的计算，因此归属于HCA Healthcare，Inc.的净收入（不包括设施销售损失（收益）和债务偿还损失），调整后的息税折旧摊销前利润可能无法与其他公司提出的其他类似标题的指标进行比较。。

(b)

（b）

The 2022 amounts are net of noncontrolling interests related to gains on sales of facilities.

2022年的金额扣除了与设施销售收益相关的非控股权益。

HCA Healthcare, Inc.

HCA医疗保健股份有限公司。

Supplemental Non-GAAP Disclosures

补充非GAAP披露

2024 Operating Results Forecast

2024年经营成果预测

(Dollars in millions, except per share amounts)

（百万美元，每股金额除外）

For the Year Ending

截至本年度

December 31, 2024

2024年12月31日

Low

低

High

高

Revenues

收入

$67,750

$70,250

Net income attributable to HCA Healthcare, Inc. (a)

归属于HCA Healthcare，Inc.（a）的净收入

$5,200

$5,600

Depreciation and amortization

折旧和摊销

3,200

3,270

Interest expense

利息支出

1,985

2,040

Provision for income taxes

所得税准备金

1,615

1,740

Net income attributable to noncontrolling interests

归属于非控股权益的净收入

850

900

Adjusted EBITDA (a) (b)

调整后息税折旧摊销前利润（a）（b）

$12,850

$13,550

Diluted earnings per share:

稀释每股收益：

Net income attributable to HCA Healthcare, Inc.

归属于HCA Healthcare，Inc.的净收入。

$19.70

$21.20

Shares used in computing diluted earnings per share (millions)

用于计算稀释每股收益的股份（百万）

264.000

The Company's forecasted guidance range is based on current plans and expectations and is subject to a number of known and unknown uncertainties and risks.

公司的预测指导范围基于当前的计划和预期，并受到许多已知和未知的不确定性和风险的影响。

________________________________________________________

(a)

（一）

The Company does not forecast the impact of items such as, but not limited to, losses (gains) on sales of facilities, losses on retirement of debt, legal claim costs (benefits) and impairments of long-lived assets because the Company does not believe that it can forecast these items with sufficient accuracy..

公司不预测诸如但不限于损失（收益）对设施销售、债务偿还损失、法律索赔成本（收益）和长期资产减值等项目的影响，因为公司不相信能够足够准确地预测这些项目。。

(b)

（b）

Adjusted EBITDA should not be considered a measure of financial performance under generally accepted accounting principles ('GAAP'). We believe Adjusted EBITDA is an important measure that supplements discussions and analysis of our results of operations. We believe it is useful to investors to provide disclosures of our results of operations on the same basis used by management.

根据公认会计原则（“GAAP”），调整后的息税折旧摊销前利润不应被视为衡量财务业绩的指标。我们认为，调整后的息税折旧摊销前利润是一项重要措施，可以补充我们对经营成果的讨论和分析。我们认为，在管理层使用的相同基础上披露我们的经营成果对投资者很有用。

Management relies upon Adjusted EBITDA as a primary measure to review and assess operating performance of its health care facilities and their management teams..

管理层将调整后的息税折旧摊销前利润作为审查和评估其医疗保健设施及其管理团队经营业绩的主要措施。。

Management and investors review both the overall performance (including net income attributable to HCA Healthcare, Inc.) and operating performance (Adjusted EBITDA) of our health care facilities. Adjusted EBITDA is utilized by management and investors to compare our current operating results with the corresponding periods during the previous year and to compare our operating results with other companies in the health care industry..

管理层和投资者审查我们医疗保健设施的整体业绩（包括归属于HCA Healthcare，Inc.的净收入）和经营业绩（调整后的息税折旧摊销前利润）。管理层和投资者利用调整后的息税折旧摊销前利润将我们目前的经营业绩与上年同期进行比较，并将我们的经营业绩与医疗保健行业的其他公司进行比较。。

Adjusted EBITDA is not a measure of financial performance under GAAP and should not be considered as an alternative to net income attributable to HCA Healthcare, Inc. as a measure of operating performance or cash flows from operating, investing and financing activities as a measure of liquidity. Because Adjusted EBITDA is not a measurement determined in accordance with GAAP and is susceptible to varying calculations, Adjusted EBITDA, as presented, may not be comparable to other similarly titled measures presented by other companies..

调整后的息税折旧摊销前利润不是GAAP下的财务业绩指标，不应被视为可归属于HCA Healthcare，Inc.的净收入的替代指标，作为经营业绩或经营、投资和融资活动现金流的衡量指标，作为流动性的衡量指标。由于调整后的息税折旧摊销前利润不是根据公认会计准则确定的衡量标准，并且容易受到不同计算的影响，因此所列调整后的息税折旧摊销前利润可能无法与其他公司提出的其他类似标题的衡量标准进行比较。。

全球产业链接平台

重庆市渝北区金星科技大厦A区5楼512室

联系电话：023-67139735（重庆）

关于我们

产品服务